Successful outpatient parenteral antibiotic therapy delivery via telemedicine
- 10 July 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 72 (10), 2898-2901
- https://doi.org/10.1093/jac/dkx203
Abstract
Most outpatient parenteral antimicrobial therapy (OPAT) services use a hospital-based model of care in which patients remain in proximity to large hospitals facilitating clinical review. We aimed to evaluate clinical outcomes and complication rates for patients living in geographically isolated locations managed by telemedicine-supported OPAT. Methods: This was a retrospective cohort study. Between 2011 and 2015, we delivered 88 episodes of care involving 83 adult patients resulting in 2261 days of OPAT. The median age was 56 years, 8 of 83 (10%) were indigenous Australian and the median Charlson comorbidity index score was 2 (IQR 1–4). The median distance of patients’ residence from our hospital was 288 km (IQR 201–715) and the median duration on the programme was 26 days (IQR 14–34). Bone and joint infections accounted for 75% of infections treated. Favourable clinical outcomes (improvement or cure) were achieved in 87% of patients and the unplanned, OPAT-related readmission rate was 8%. Nineteen percent and 10% of patients had drug-related and line-related adverse effects, respectively. Despite a complex case mix, our adverse event and readmission rates are similar to the published literature describing a non-telemedicine model to deliver OPAT. High rates of favourable clinical outcomes and likely cost benefits suggest that telemedicine-supported OPAT is an efficacious and safe substitute for inpatient care in our setting.This publication has 12 references indexed in Scilit:
- Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy RegistryFuture Microbiology, 2016
- A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT)Infectious Diseases, 2014
- Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and StabilityPLOS ONE, 2014
- Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease PhysiciansInfection Control & Hospital Epidemiology, 2014
- Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted casesJournal of Antimicrobial Chemotherapy, 2014
- Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycinJournal of Antimicrobial Chemotherapy, 2009
- A Brief Retrospective Review of Medical Records Comparing Outcomes for Inpatients Treated via Telehealth Versus In-Person Protocols: Is Telehealth Equally Effective as In-Person Visits for Treating Neutropenic Fever, Bacterial Pneumonia, and Infected Bacterial Wounds?Telemedicine and e-Health, 2008
- Treating Acute Infections by Telemedicine in the HomeClinical Infectious Diseases, 2004
- Practice Guidelines for Outpatient Parenteral Antimicrobial TherapyClinical Infectious Diseases, 2004